Diagnostics & Research Stocks in the S&P 500
Every S&P 500 company classed as Diagnostics & Research: 12 of the 60 stocks in the Healthcare sector. Highest fundamentals score first.
Quick answer
S&P 500 Diagnostics & Research stocks: 12 (12 scored). Median score 51/100, below the S&P 500 median of 54. Strong (80+): 0. Weak (under 40): 2. Highest scores: Labcorp (65), Quest Diagnostics (63) and Idexx Laboratories (61).
All 12 Diagnostics & Research stocks, ranked by score
12 stocks
| Labcorp Holdings Inc. Common StockLabcorp LH | 65 | US$ 29.4b | 70 | 83 | 63 | 33 | 75 |
| Quest Diagnostics Incorporated Common StockQuest Diagnostics DGX | 63 | US$ 27.7b | 80 | 83 | 75 | 0 | 75 |
| IDEXX Laboratories, Inc.Idexx Laboratories IDXX | 61 | US$ 43.4b | 90 | 67 | 50 | 0 | 92 |
| Agilent Technologies, Inc. Common StockAgilent Technologies A | 57 | US$ 49.3b | 80 | 83 | 63 | 0 | 58 |
| Revvity, Inc. Common StockRevvity RVTY | 54 | US$ 17.5b | 30 | 83 | 75 | 0 | 75 |
| Mettler-Toledo International, Inc. Common StockMettler Toledo MTD | 51 | US$ 33.6b | 80 | 50 | 38 | 0 | 83 |
| Thermo Fisher Scientific Inc Common StockThermo Fisher Scientific TMO | 51 | US$ 257.7b | 50 | 83 | 63 | 0 | 60 |
| Danaher Corporation Common StockDanaher DHR | 50 | US$ 163.4b | 50 | 100 | 50 | 0 | 50 |
| Illumina, Inc.Illumina ILMN | 48 | US$ 35.6b | 30 | 83 | 75 | 0 | 50 |
| IQVIA Holdings, Inc. Common StockIQVIA IQV | 42 | US$ 44.1b | 63 | 17 | 75 | 0 | 63 |
| Waters Corporation Common StockWaters WAT | 37 | US$ 45.4b | 25 | 83 | 63 | 0 | 10 |
| Charles River Laboratories International, Inc. Common StockCharles River Laboratories CRL | 24 | US$ 17.2b | 0 | 17 | 50 | 0 | 50 |
Common questions
This site lists 12 S&P 500 stocks in the Diagnostics & Research sub-sector, part of the Healthcare sector. 12 of them have enough data for a score.
As of this site's latest data, Labcorp Holdings Inc. Common Stock (LH) has the highest fundamentals score in Diagnostics & Research, at 65/100. Top three: Labcorp (65), Quest Diagnostics (63) and Idexx Laboratories (61).
The median Diagnostics & Research stock scores 51/100, below the S&P 500 median of 54. Split: 0 strong, 10 okay, 2 weak. Its biggest lead over the market is Financial Safety: 69 vs 63 for the whole S&P 500. Its biggest shortfall is Price Fairness: 3 vs 21 for the whole S&P 500.
Charles River Laboratories International, Inc. Common Stock (CRL), at 24/100, the lowest of the 12 scored Diagnostics & Research stocks. Its stock page shows which measures pull it down. A score reads the latest published numbers, not a forecast.
Each stock gets 0-100 from five pillars: Business Strength, Financial Safety, Cash & Dividends, Price Fairness and Risk, built from its published financial statements and share price. Banks and REITs use their own cutoffs where normal rules would misjudge them. Full rules: https://scoreyourstock.com/how.
Other sub-sectors in Healthcare
Medical Devices (10) · Drug Manufacturers - General (9) · Medical Instruments & Supplies (8)